The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Filter
Locations
Result types
Type of company
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
Lock keywords
Exclude keywords
Optional keywords
Singapore, Singapore
51-100 Employees
In 2013, Unistraw was acquired by SRS Life Sciences to address these by kickstarting the cycle of health and positivity, reframing compliance as a simple, enjoyable part of life. Our mission is to convert the compostable straw into a mainstream drug delivery system by offering our technology as a platform to other businesses. Award-Winning Drug Delivery System for Patient Centricity - CPhI Pharma. Straw Delivery System with beads inside the straws that add flavor, energy, vitamins, nutrition, and medication to any beverage, including water. Straw Delivery System where the inner wall of the straw is lined with active ingredients. But consumer surveys have shown that administering medicines through straws offers an even higher (90%) compliance compared to only 40% through syrups which until now has been conventionally considered the most preferred dosage form.
+
Featured
drug delivery
... We are a Contract Development and Manufacturing Organization (CDMO) that offers our compostable straw as a drug delivery platform. ...
McKinney, United States
1-10 Employees
2010
DrugDel Consulting, LLC is a pharmaceutical consultancy that provides a full range of technical and regulatory advisory services for the development of ophthalmic or ocular dose forms and products with particular emphasis on creating effective, stable and safe formulations and controlled release systems.
+
Featured
Drug Delivery Consulting - Pharma - Ophthalmology | Alan L. Weiner,Ph.D.| drugdelconsulting.com
... Drug Delivery Consulting - Pharma - Ophthalmology | Alan L. Weiner,Ph.D.| drugdelconsulting. ...
Warsaw, Poland
1-10 Employees
2013
Our dextran drug delivery system was first developed at the Faculty of Chemical and Process Engineering of the Warsaw University of Technology in the Biomedical Engineering Laboratory established by Dr. Ciach decided to commercialize the technology and founded NanoVelos. Technology based on polysaccharide nanoparticles is orginal solution patented by NanoVelos SA In vitro experiments: Assesment of cell viability (MTT assay, HeLa cells etc.) demonstrates that examined drugs released from nanoparticles retains its potential to induce cell death. The main goals of those studies is to collect the data providing submission to FDA or EMA. These interventions may be medical products, such as drugs or devices; procedures; or changes to participants’ behavior, such as diet. When a new product or approach is being studied, it is not usually known whether it will be helpful, harmful, or no different than available alternatives. The EMA (European Medicines Agency), is the European Union’s equivalent to the U.S. Treatments are not one-size-fits-all, that’s why we focus on various areas.
+
Featured
NanoVelos | Nanoparticles for drug delivery systems | Biomedical StartUp
... Nano drug delivery ...
+
Featured
Revolutionizing drug delivery
... HHC Medical is a health tech startup developing a platform technology for targeted and non-invasive drug delivery via wireless ...
Cary, United States
11-50 Employees
2015
Located in Research Triangle Park in North Carolina, ZY Therapeutics has an interdisciplinary R&D team and 4,500+ sf lab space right in the heart of the southeast bio-hub. ZY has developed multiple platform technologies and related patents were filed to protect global rights. ZY Therapeutics is actively seeking funding and collaboration to further develop our platform technologies and promising candidates. We look forward to taking our nano-formulations to clinic in 2019 and beyond.
+
Featured
ZY Drug Delivery Technology Platforms
... Vitamin Modified Polymeric Carbohydrate Drug Encapsulation Nano-delivery ...
Mansfield, United States
1-10 Employees
2017
VeraMorph is a lean specialty pharmaceutical company leveraging internal expertise in materials science, pharmaceutical formulation, and process chemistry to efficiently develop high value, clinically differentiated drug products leveraging our platform oral drug delivery technology, while leveraging the capabilities of commercialization partners to bring those products to market in a cost-effective, accelerated timeline. VeraMorph is creating value through the development of both a portfolio of patent-protected oral drug products and out-licensing of our platform technology to pharmaceutical partners developing novel drug products across several disease areas. VeraMorph has developed a proprietary oral drug delivery platform that we are leveraging to help companies improve and accelerate clinical translation of poorly soluble lead compounds and build a specialty drug product portfolio comprised of clinically-differentiated oral versions of approved drugs. VeraMorph is led by a small team of experienced and passionate entrepreneurs and executives with drug delivery and product design expertise. We are actively seeking driven and skilled chemists, engineers, and scientists to build our R&D team with a collaborative and fast-pace lab environment. VeraMorph CEO, Doug Godfrin, will present on the company's platform technology at AAPS PharmSci 360. VeraMorph's platform technology has been accepted into the FDA Novel Excipient Review Program. The presentation will be delivered on Tuesday, October 24 in the Formulation and Delivery Track to an audience of scientists and executives with a focus on drug delivery technologies.
+
Featured
Drug Delivery | Veramorph Materials | United States
... Veramorph is a specialty pharmaceutical start-up leveraging its universal oral drug delivery platform to expand opportunities to commercialize oral drug products with an internal pipeline of orally reformulated products and partnerships on pre-clinical compounds. ...
Austin, United States
11-50 Employees
2006
NanoMedical Systems develops novel drug-delivery devices based on its proprietary nStrada™ nanofluidics platform for sustained release of chronic therapies. The nStrada Drug Delivery Platform utilizes state-of-the-art semiconductor manufacturing methods and biocompatible materials and features a tunable high-density array of precision nanochannels that regulates the delivery of drug molecules from an internal reservoir. No power or moving parts are required for long-term constant delivery.
+
Featured
Nanotechnology Transforming Drug Delivery
... Nanochannel Chip Drug Delivery Technology Platform ...
Ghent, Belgium
1-10 Employees
Research, development and manufacturing of biomedical and pharmaceutical applications, specializing in intrauterine and vaginal drug delivery systems. APCOR R&M uses cutting edge technologies and materials to develop new drug delivery systems. Leveraging our extensive knowhow and knowledge in the field of intrauterine and vaginal drug delivery parmaceuticals and materials, we help our partners in developing new and innovative controlled release systems or improve existing release systems. Wildemeersch continued working on new intrauterine approaches and treatment systems based on polymeric drug delivery. Wim Thielemans at the University of Leuven (KULAK), developing sustainable and innovative materials. APCOR R&M can provide all of these and help build the future of controlled release systems for intrauterine and vaginal drug delivery. Partnering with APCOR R&M provides your company with expertise in:.
+
Featured
Controlled Release Drug Delivery | APCOR R&M
... APCOR R&M develops biomedical and pharmaceutical applications specifically for intrauterine and vaginal drug delivery systems. APCOR R&M also collaborates with partners on pharmaceutical compounds and controlled release systems. ...
Davis, United States
1-10 Employees
2017
A multifunctional nano capsid capable of efficiently delivering therapeutic and diagnostic agents for targeting diverse disease models through multiple routes of administration. Get ready to revolutionize the world of drug delivery. BioCapZ is a groundbreaking nano-delivery system that surpasses all others on the market, including AAV, SV40, liposomes, and polymers. This patented technology can be customized through chemical and genetic engineering to maximize drug delivery efficiency. Invest in BioCapZ now and join us in shaping the future of drug delivery. Furthermore, the viral capsid’s surface can be engineered to allow targeted delivery to specific tissues and present multiple epitopes on the surface for vaccine purposes. With relatively quick production time and cost, BioCapZ provides an easy-to-store nanoplatform using an icosahedral scaffold for a broad range of therapeutic and theranostic applications.
+
Featured
The most powerful lifestyle drug delivery system of our time.
... The most powerful lifestyle drug delivery system of our time. ...
Dallas, United States
1-10 Employees
2000
TissueGen solves for unmet needs through the development of transformative drug delivery technologies that reduce treatment burden and improve clinical outcomes. TissueGen was founded in 2000 as a spin-out of the Joint Program of Biomedical Engineering at The University of Texas Southwestern Medical Center at Dallas, and The University of Texas at Arlington. TissueGen’s initial technology was developed by our founder, Dr. As we developed, we realized this simple emulsion system could be dramatically improved by incorporating various forms of nanotechnology. We focus on preserving the biological activity of very sensitive therapeutics such as growth factors and antibodies when they are loaded into polymeric systems for slow, sustained release. The two-phase drug delivery system has remained a philosophical pillar and has now borne unprecedented results for long-term delivery of these sensitive therapeutics.
+
Featured
Drug Delivery | Tissuegen | Dallas
... TissueGen solves for unmet needs through the development of transformative drug delivery technologies that reduce treatment burden and improve clinical outcomes. We create life changing treatment modalities for patients and their caregivers, treating both acute and chronic conditions. ...
Technologies which have been searched by others and may be interesting for you:
Some interesting numbers and facts about the results you have just received for Drug Delivery
| Country with most fitting companies | United States |
| Amount of fitting manufacturers | 488 |
| Amount of suitable service providers | 311 |
| Average amount of employees | 1-10 |
| Oldest suiting company | 2000 |
| Youngest suiting company | 2019 |
20%
40%
60%
80%
Drug delivery refers to the methodological techniques employed to administer pharmaceutical compounds in the body to safely achieve their desired therapeutic effect. This multifaceted science integrates principles from chemistry, biology, physics, and engineering to optimize the efficacy and distribution of medication. The core objective of drug delivery systems is to transport a pharmaceutical compound directly to its target site in a controlled manner, thereby maximizing its effectiveness while minimizing side effects and systemic toxicity. Innovations in this field, such as nanoparticle delivery systems, transdermal patches, and targeted delivery technologies, have significantly enhanced the precision with which treatments can be delivered, particularly for chronic diseases like cancer, diabetes, and heart disease. The impact of advanced drug delivery systems is profound, offering potential for personalized medicine through the development of formulations that can be tailored to the individual's genetic makeup, thereby optimizing therapeutic outcomes. Furthermore, these technologies extend the effective lifespan of drugs, improve patient compliance by reducing the frequency of dosage, and can even resurrect drugs previously deemed too toxic by selectively targeting diseased cells and bypassing healthy ones. As such, the evolution of drug delivery technologies continues to play a pivotal role in the advancement of modern medicine, transforming the landscape of treatment protocols and enhancing the quality of life for patients worldwide.
1. Targeted Action
One of the most significant advantages of drug delivery systems is their ability to target specific sites within the body. This precision reduces the risk of side effects and increases the effectiveness of the medication, providing a more efficient treatment compared to traditional methods.
2. Controlled Release
Drug delivery technologies allow for the controlled release of medication over time. This ensures a steady state of drug concentration in the bloodstream, leading to improved patient compliance and convenience by reducing the frequency of doses required.
3. Enhanced Stability
Many drug delivery systems enhance the stability of the drugs they carry, protecting them from environmental factors such as pH and enzymes that could degrade their effectiveness. This results in a longer shelf-life and maintains the drug’s efficacy until it reaches its target.
4. Reduced Dosage Frequency
By optimizing the release profile of medications, drug delivery systems can significantly reduce the number of doses a patient needs to take. This not only improves patient compliance but also minimizes potential side effects associated with higher doses of conventional medication delivery.
While evaluating the different suppliers make sure to check the following criteria:
1. Regulatory Compliance
Ensure the supplier meets all local and international regulatory standards for drug delivery systems, including FDA approval for the U.S. market.
2. Innovation and Technology
Assess the supplier's commitment to innovation and their use of cutting-edge technology in drug delivery solutions.
3. Quality Assurance Processes
Verify the supplier's quality assurance protocols, including testing for stability, compatibility, and efficacy of the drug delivery system.
4. Supply Chain Reliability
Evaluate the reliability and transparency of the supplier's supply chain, ensuring timely delivery and minimal disruption.
5. Customization Capabilities
Check if the supplier offers customization options to tailor the drug delivery systems according to specific drug formulations and patient needs.
6. Cost-Effectiveness
Consider the cost-effectiveness of the supplier's solutions without compromising on quality and efficiency.
7. Customer Support and Services
Ensure the supplier provides excellent customer support, including technical assistance and after-sales services.
In the pharmaceutical industry, drug delivery systems play a crucial role in ensuring medications are efficiently transported and absorbed by the body. These systems are particularly important for drugs that are sensitive to the digestive system or require precise dosage control. For instance, time-release capsules enable a steady release of medication, improving patient compliance and treatment outcomes. The biotechnology sector utilizes advanced drug delivery methods, such as nanoparticle carriers, to target specific cells or tissues. This precision reduces side effects and enhances the effectiveness of treatments, especially in the fight against cancer. Nanoparticles can deliver chemotherapy directly to cancer cells, minimizing damage to healthy tissues and improving patient quality of life. In the cosmetics industry, drug delivery technologies are employed to enhance skin penetration of active ingredients in skincare products. By ensuring that these ingredients reach deeper skin layers, products can offer more pronounced and lasting effects. Liposome encapsulation, for example, protects active ingredients, allowing them to maintain their efficacy until they reach their target within the skin. Lastly, the veterinary sector benefits from drug delivery systems to ensure animals receive accurate dosages of medications, vaccines, or supplements. Specialized formulations cater to different species' unique digestive systems and habits, ensuring effective treatment and preventive care. This application underscores the versatility and importance of drug delivery systems across various B2B contexts.
Drug delivery systems currently span across various Technology Readiness Levels (TRLs), largely influenced by the complexity of the delivery mechanism and the type of medication being administered. At the lower end, basic oral and injectable delivery methods are at TRL 9, having been fully commercialized and integrated into healthcare practices worldwide. These systems have undergone extensive clinical trials, proving their efficacy and safety for widespread use. On the other hand, more advanced drug delivery technologies, such as nanoparticle systems and targeted delivery mechanisms, are generally positioned between TRLs 4 to 6. These innovative approaches are in the developmental or testing phase, with prototypes demonstrating considerable promise in laboratory settings but still requiring refinement and extensive human clinical trials to ascertain their effectiveness and potential side effects. The discrepancy in TRLs reflects technical challenges, including ensuring precise targeting, overcoming biological barriers, and achieving controlled release rates. Furthermore, the integration of biocompatible materials in drug delivery systems adds another layer of complexity, necessitating rigorous biocompatibility testing to ensure they do not elicit adverse immune responses. Thus, the current TRL of drug delivery technologies is a spectrum that mirrors the breadth of innovation and technical hurdles being navigated in the quest for more effective and patient-friendly medication administration methods.
In the Short-Term, advancements in drug delivery are expected to focus on enhancing precision and minimizing invasiveness. Technologies like micro-needle patches for vaccines and medication are poised for widespread adoption. These patches will not only improve patient comfort but also offer controlled release mechanisms, ensuring consistent drug delivery over time. Additionally, the integration of smart technology in inhalers and wearable drug delivery systems will allow for better monitoring and management of chronic conditions, providing real-time feedback to both patients and healthcare providers. Moving into the Mid-Term phase, we will witness significant strides in nanotechnology and bioengineered delivery systems. These innovations aim to revolutionize targeted therapy, enabling drugs to be delivered directly to diseased cells without affecting surrounding healthy tissues. This precision will drastically reduce side effects and increase the efficacy of treatments. The development of biocompatible nanocarriers will also enhance the solubility and bioavailability of drugs, opening new avenues for treating complex diseases like cancer and Alzheimer’s. In the Long-Term, the horizon of drug delivery technology will expand to include autonomous systems capable of responding to physiological changes in real-time. These advanced systems, fueled by breakthroughs in bioresponsive materials and artificial intelligence, will autonomously adjust dosage based on the body's immediate needs, ushering in a new era of personalized medicine. The integration of genetic profiling in drug delivery mechanisms could also enable highly individualized treatments, tailored to the genetic makeup of each patient, minimizing trial and error in drug prescriptions and maximizing treatment effectiveness.
Some interesting questions that has been asked about the results you have just received for Drug Delivery
What are related technologies to Drug Delivery?
Based on our calculations related technologies to Drug Delivery are Biomedical (Red), Bioinformatics (Gold), Environmental Biotechnology (Grey), Agricultural Biotechnology (Green), Food Related Biotechnology (Yellow)
Which industries are mostly working on Drug Delivery?
The most represented industries which are working in Drug Delivery are Health Care, Biotechnology, Science and Engineering, Manufacturing, Professional Services
How does ensun find these Drug Delivery Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.
